Application of multi-omics and pharmacological studies to discover potential new therapeutics for COVID-19
COVID-19 is the largest pandemic of the 21st century, affecting over 6.6 million individuals and claiming over 391,000 lives worldwide as of June 4, 2020. It is caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), which uses a receptor to gain entry into the host and cause active infection. This project involves the expertise of PROOF Centre and Professors Don Sin and Pascal Bernatchez. We would like to apply genomic studies and test new drugs studies to 1) better understand the genetics behind COVID-19 and 2) test these newly synthesized compounds for fighting this disease. These results will be used to guide future clinical studies, enabling new treatment options for COVID-19.